Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Cantor Fitzgerald Downgrades Acumen Pharmaceuticals to Underweight From Overweight

Cantor Fitzgerald Downgrades Acumen Pharmaceuticals to Underweight From Overweight

MT newswireMT newswire2026/10/30 16:09
By:MT newswire
12:09 PM EDT, 10/30/2026 (MT Newswires) -- Acumen Pharmaceuticals (ABOS) has an average rating of hold and mean price target of $4.40, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) Price: 0.27, Change: -2.02, Percent Change: -88.12
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!